{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:11:02Z","timestamp":1787314262856,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01926-7","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T07:50:01Z","timestamp":1759218601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Five CGD-Linked CYBB Mutations in Chinese Patients: Insights Into Predicting IFN-\u03b3 Treatment Efficacy"],"prefix":"10.1007","volume":"45","author":[{"given":"Yi-Xin","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Pin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Man","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Qiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Fu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"1926_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12016-009-8136-z","volume":"38","author":"SM Holland","year":"2010","unstructured":"Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol. 2010;38:3\u201310.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1926_CR2","doi-asserted-by":"publisher","unstructured":"Leiding JW, Holland SM. Chronic granulomatous disease. Stiehm's Immune Deficiencies. 2020;829\u201347. https:\/\/doi.org\/10.1016\/B978-0-12-816768-7.00037-5","DOI":"10.1016\/B978-0-12-816768-7.00037-5"},{"issue":"5","key":"1926_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1365-3083.2010.02501.x","volume":"73","author":"E de Oliveira-Junior","year":"2011","unstructured":"de Oliveira-Junior E, Bustamante J, Newburger PE, Condino-Neto A. The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand J Immunol. 2011;73(5):420\u201327.","journal-title":"Scand J Immunol"},{"key":"1926_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fimmu.2019.00073","volume":"10","author":"T Li","year":"2019","unstructured":"Li T, Zhou X, Ling Y, Jiang N, Ai J, Wu J, et al. Genetic and clinical profiles of disseminated Bacillus Calmette-Gu\u00e9rin disease and chronic granulomatous disease in China. Front Immunol. 2019;10:73.","journal-title":"Front Immunol"},{"issue":"1","key":"1926_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10875-016-0352-8","volume":"37","author":"H Xu","year":"2017","unstructured":"Xu H, Tian W, Li S-J, Zhang L-Y, Liu W, Zhao Y, et al. Erratum to: clinical and molecular features of 38 children with chronic granulomatous disease in mainland China. J Clin Immunol. 2017;37(1):5.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1926_CR6","first-page":"8745254","volume":"2017","author":"J Wu","year":"2017","unstructured":"Wu J, Wang W-F, Zhang Y-D, Chen T-X. Clinical features and genetic analysis of 48 patients with chronic granulomatous disease in a single center study from Shanghai, China (2005\u20132015): new studies and a literature review. J Immunol Res. 2017;2017(1):8745254.","journal-title":"J Immunol Res"},{"key":"1926_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s10875-019-00680-x","volume":"39","author":"S Wang","year":"2019","unstructured":"Wang S, Wang T, Xiang Q, Xiao M, Cao Y, Xu H, et al. Clinical and molecular features of chronic granulomatous disease in mainland China and a XL-CGD female infant patient after prenatal diagnosis. J Clin Immunol. 2019;39:762\u201375.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1926_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/pai.13033","volume":"30","author":"LW Gao","year":"2019","unstructured":"Gao LW, Yin QQ, Tong YJ, Gui JG, Liu Xy, Feng Xl, et al. Clinical and genetic characteristics of Chinese pediatric patients with chronic granulomatous disease. Pediatr Allergy Immunol. 2019;30(3):378\u201386.","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"1926_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mycmed.2011.12.079","volume":"22","author":"S Bassiri-Jahromi","year":"2012","unstructured":"Bassiri-Jahromi S, Doostkam A. Fungal infection and increased mortality in patients with chronic granulomatous disease. J Mycol Med. 2012;22(1):52\u20137.","journal-title":"J Mycol Med"},{"issue":"9","key":"1926_CR10","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/microorganisms11092233","volume":"11","author":"AA Justiz-Vaillant","year":"2023","unstructured":"Justiz-Vaillant AA, Williams-Persad AF-A, Arozarena-Fundora R, Gopaul D, Soodeen S, Asin-Milan O, et al. Chronic granulomatous disease (CGD): commonly associated pathogens, diagnosis and treatment. Microorganisms. 2023;11(9):2233.","journal-title":"Microorganisms"},{"key":"1926_CR11","doi-asserted-by":"crossref","unstructured":"Henriet S, Verweij PE, Holland SM, Warris A. Invasive fungal infections in patients with chronic granulomatous disease. Hot Top Infect Immun Child IX. 2013;27\u201355.","DOI":"10.1007\/978-1-4614-4726-9_3"},{"issue":"8","key":"1926_CR12","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","volume":"60","author":"BE Marciano","year":"2015","unstructured":"Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60(8):1176\u201383.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1926_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1159\/000507366","volume":"181","author":"D Aygun","year":"2020","unstructured":"Aygun D, Koker MY, Nepesov S, Koker N, van Leeuwen K, de Boer M, et al. Genetic characteristics, infectious, and noninfectious manifestations of 32 patients with chronic granulomatous disease. Int Arch Allergy Immunol. 2020;181(7):540\u201350.","journal-title":"Int Arch Allergy Immunol"},{"key":"1926_CR14","doi-asserted-by":"publisher","first-page":"625320","DOI":"10.3389\/fimmu.2021.625320","volume":"12","author":"A Rawat","year":"2021","unstructured":"Rawat A, Vignesh P, Sudhakar M, Sharma M, Suri D, Jindal A, et al. Clinical, immunological, and molecular profile of chronic granulomatous disease: a multi-centric study of 236 patients from India. Front Immunol. 2021;12:625320.","journal-title":"Front Immunol"},{"key":"1926_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fped.2019.00107","volume":"7","author":"K Lutzkanin","year":"2019","unstructured":"Lutzkanin K, McKeone DJ, Greiner R, Andreae DA. A novel mutation in chronic granulomatous disease: treating the family, not just the patient. Front Pediatr. 2019;7:107.","journal-title":"Front Pediatr"},{"key":"1926_CR16","doi-asserted-by":"crossref","unstructured":"Roos D. Chronic granulomatous disease. Nadph Oxidases: Methods Protocol. 2019;531\u201342.","DOI":"10.1007\/978-1-4939-9424-3_32"},{"issue":"2","key":"1926_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/cei.12202","volume":"175","author":"D Roos","year":"2014","unstructured":"Roos D, Boer M. Molecular diagnosis of chronic granulomatous disease. Clin Exp Immunol. 2014;175(2):139\u201349.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1926_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bcmd.2010.07.012","volume":"45","author":"D Roos","year":"2010","unstructured":"Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, Avcin T, de Boer M, Bustamante J, Condino-Neto A, Di Matteo G. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells, Molecules, and Diseases. 2010;45(3):246\u201365.","journal-title":"Blood Cells, Molecules, and Diseases."},{"issue":"1","key":"1926_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.hoc.2012.11.002","volume":"27","author":"SM Holland","year":"2013","unstructured":"Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27(1):89\u201399.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8029","key":"1926_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-024-07866-3","volume":"633","author":"AA Arias","year":"2024","unstructured":"Arias AA, Neehus A-L, Ogishi M, Meynier V, Krebs A, Lazarov T, et al. Tuberculosis in otherwise healthy adults with inherited TNF deficiency. Nature. 2024;633(8029):417\u201325.","journal-title":"Nature"},{"issue":"6","key":"1926_CR21","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1086\/301874","volume":"62","author":"J Rae","year":"1998","unstructured":"Rae J, Newburger PE, Dinauer MC, Noack D, Hopkins PJ, Kuruto R, et al. X-linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase. Am J Hum Genet. 1998;62(6):1320\u201331.","journal-title":"Am J Hum Genet"},{"issue":"10","key":"1926_CR22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nrmicro1004","volume":"2","author":"FC Fang","year":"2004","unstructured":"Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol. 2004;2(10):820\u201332.","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"1926_CR23","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1182\/blood.2023022590","volume":"144","author":"B Wolach","year":"2024","unstructured":"Wolach B, Gavrieli R, Wolach O, Salamon P, de Boer M, van Leeuwen K, et al. Genotype-phenotype correlations in chronic granulomatous disease: insights from a large national cohort. Blood. 2024;144(12):1300\u201313.","journal-title":"Blood"},{"issue":"3","key":"1926_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","volume":"79","author":"BH Segal","year":"2000","unstructured":"Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Med. 2000;79(3):170\u2013200.","journal-title":"Med"},{"issue":"3","key":"1926_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ni.1992","volume":"12","author":"J Bustamante","year":"2011","unstructured":"Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011;12(3):213\u201321.","journal-title":"Nat Immunol"},{"key":"1926_CR26","first-page":"1","volume":"17","author":"S Pashaeypoor","year":"2018","unstructured":"Pashaeypoor S, Sayadi L, Khosroparviz K. Primary immunodeficiency diseases. 2017.","journal-title":"Iranian Journal of Allergy, Asthma and Immunology"},{"key":"1926_CR27","doi-asserted-by":"publisher","first-page":"102587","DOI":"10.1016\/j.bcmd.2021.102587","volume":"90","author":"D Roos","year":"2021","unstructured":"Roos D, Van Leeuwen K, Hsu AP, Priel DL, Begtrup A, Brandon R, et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells Mol Dis. 2021;90:102587.","journal-title":"Blood Cells Mol Dis"},{"key":"1926_CR28","doi-asserted-by":"crossref","unstructured":"Meischl C, Roos D. The molecular basis of chronic granulomatous disease. Springer seminars in immunopathology. 1998;19(4):417\u201334.","DOI":"10.1007\/BF00792600"},{"issue":"1","key":"1926_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0022-3476(96)70437-7","volume":"128","author":"SJ Vowells","year":"1996","unstructured":"Vowells SJ, Fleisher TA, Sekhsaria S, Alling DW, Maguire TE, Malech HL. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr. 1996;128(1):104\u20137.","journal-title":"J Pediatr"},{"key":"1926_CR30","doi-asserted-by":"publisher","first-page":"639226","DOI":"10.3389\/fimmu.2021.639226","volume":"12","author":"FG Bakri","year":"2021","unstructured":"Bakri FG, Mollin M, Beaumel S, Vigne B, Roux-Buisson N, Al-Wahadneh AM, et al. Second report of chronic granulomatous disease in Jordan: clinical and genetic description of 31 patients from 21 different families, including families from Lybia and Iraq. Front Immunol. 2021;12:639226.","journal-title":"Front Immunol"},{"issue":"3","key":"1926_CR31","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1002\/jcb.27718","volume":"120","author":"JB Fraz\u00e3o","year":"2019","unstructured":"Fraz\u00e3o JB, Colombo M, Simillion C, Bilican A, Keller I, W\u00fcthrich D, et al. Gene expression in chronic granulomatous disease and interferon-\u03b3 receptor-deficient cells treated in vitro with interferon-\u03b3. J Cell Biochem. 2019;120(3):4321\u201332.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1926_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5114\/ceji.2015.50833","volume":"40","author":"S Filiz","year":"2015","unstructured":"Filiz S, Uygun DFK, K\u00f6ksoy S, \u015eahin E, Ye\u0399\u011fin O. Clinical immunology in vitro interferon \u03b3 improves the oxidative burst activity of neutrophils in patients with chronic granulomatous disease with a subtype of gp91phox deficiency. Cent Eur J Immunol. 2015;40(1):54\u201360.","journal-title":"Cent Eur J Immunol"},{"issue":"3","key":"1926_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/bcmd.1995.0028","volume":"21","author":"LS Bemiller","year":"1995","unstructured":"Bemiller LS, Roberts DH, Starko KM, Curnutte JT. Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease. Blood Cells Mol Dis. 1995;21(3):239\u201347.","journal-title":"Blood Cells Mol Dis"},{"issue":"6693","key":"1926_CR34","doi-asserted-by":"publisher","first-page":"eadl2016","DOI":"10.1126\/science.adl2016","volume":"384","author":"J-L Casanova","year":"2024","unstructured":"Casanova J-L, MacMicking JD, Nathan CF. Interferon-\u03b3 and infectious diseases: lessons and prospects. Science. 2024;384(6693):eadl2016.","journal-title":"Science"},{"key":"1926_CR35","doi-asserted-by":"publisher","first-page":"803763","DOI":"10.3389\/fimmu.2021.803763","volume":"12","author":"TL-H Chiu","year":"2022","unstructured":"Chiu TL-H, Leung D, Chan K-W, Yeung HM, Wong C-Y, Mao H, et al. Phenomic analysis of chronic granulomatous disease reveals more severe integumentary infections in X-linked compared with autosomal recessive chronic granulomatous disease. Front Immunol. 2022;12:803763.","journal-title":"Front Immunol"},{"issue":"2","key":"1926_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/cei.13520","volume":"203","author":"M Mollin","year":"2021","unstructured":"Mollin M, Beaumel S, Vigne B, Brault J, Roux-Buisson N, Rendu J, et al. Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants\u2013identification of 11 novel mutations in CYBB. Clin Exp Immunol. 2021;203(2):247\u201366.","journal-title":"Clin Exp Immunol"},{"key":"1926_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10875-020-00750-5","volume":"40","author":"L Blancas-Galicia","year":"2020","unstructured":"Blancas-Galicia L, Santos-Ch\u00e1vez E, Deswarte C, Mignac Q, Medina-Vera I, Le\u00f3n-Lara X, et al. Genetic, immunological, and clinical features of the first Mexican cohort of patients with chronic granulomatous disease. J Clin Immunol. 2020;40:475\u201393.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1926_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaci.2015.11.041","volume":"138","author":"F Conti","year":"2016","unstructured":"Conti F, Lugo-Reyes SO, Galicia LB, He J, Aksu G, de Oliveira EB Jr, et al. Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases. J Allergy Clin Immunol. 2016;138(1):241\u201348","journal-title":"J Allergy Clin Immunol"},{"key":"1926_CR39","doi-asserted-by":"crossref","unstructured":"Lin L, Gong Z, Yin G, Lu G, Peng J. A twin with a novel mutation in CYBB induced X-linked chronic granulomatous disease: a rare case report of misdiagnosis as congenital cystic lung disease. 2024.","DOI":"10.21203\/rs.3.rs-5297507\/v1"},{"issue":"1","key":"1926_CR40","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12887-023-04158-z","volume":"23","author":"Z Li","year":"2023","unstructured":"Li Z, Chen H, Feng X, Ruan Y, Yang M. Hematopoietic stem cell transplantation for CYBB heterozygous mutation resulting in very early onset inflammatory bowel disease in children: a case report. BMC Pediatr. 2023;23(1):348.","journal-title":"BMC Pediatr"},{"issue":"2","key":"1926_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pedneo.2022.06.014","volume":"64","author":"E Altamimi","year":"2023","unstructured":"Altamimi E, Samara D, Issa DB, Jaradat S, Hayajneh W. Genotype-phenotype correlation in Jordanian children with genetically-proven familial Mediterranean fever: the effect of R202Q mutation. Pediatr Neonatol. 2023;64(2):183\u201391.","journal-title":"Pediatr Neonatol"},{"issue":"3","key":"1926_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2353\/jmoldx.2010.090147","volume":"12","author":"HR Hill","year":"2010","unstructured":"Hill HR, Augustine NH, Pryor RJ, Reed GH, Bagnato JD, Tebo AE, et al. Rapid genetic analysis of X-linked chronic granulomatous disease by high-resolution melting. J Mol Diagn. 2010;12(3):368\u201376.","journal-title":"J Mol Diagn"},{"issue":"6","key":"1926_CR43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/antiox10060891","volume":"10","author":"M Chiriaco","year":"2021","unstructured":"Chiriaco M, Salfa I, Ursu GM, Cifaldi C, Di Cesare S, Rossi P, et al. Immunological aspects of X-linked chronic granulomatous disease female carriers. Antioxidants. 2021;10(6):891.","journal-title":"Antioxidants"},{"issue":"8","key":"1926_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJM199102213240801","volume":"324","author":"Group* ICGDCS","year":"1991","unstructured":"Group* ICGDCS. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. New Engl J Med. 1991;324(8):509\u201316.","journal-title":"New Engl J Med"},{"issue":"3","key":"1926_CR45","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s10875-022-01391-6","volume":"43","author":"SO Lugo Reyes","year":"2023","unstructured":"Lugo Reyes SO, Gonz\u00e1lez Garay A, Gonz\u00e1lez Bobadilla NY, Rivera Liz\u00e1rraga DA, Madrigal Paz AC, Medina-Torres EA, et al. Efficacy and safety of interferon-gamma in chronic granulomatous disease: a systematic review and meta-analysis. J Clin Immunol. 2023;43(3):578\u201384.","journal-title":"J Clin Immunol"},{"key":"1926_CR46","doi-asserted-by":"publisher","first-page":"1384550","DOI":"10.3389\/fped.2024.1384550","volume":"12","author":"O Staudacher","year":"2024","unstructured":"Staudacher O, von Bernuth H. Clinical presentation, diagnosis, and treatment of chronic granulomatous disease. Front Pediatr. 2024;12:1384550.","journal-title":"Front Pediatr"},{"issue":"14","key":"1926_CR47","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1073\/pnas.85.14.5215","volume":"85","author":"PE Newburger","year":"1988","unstructured":"Newburger PE, Ezekowitz R, Whitney C, Wright J, Orkin SH. Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma. Proc Natl Acad Sci. 1988;85(14):5215\u201319.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"1926_CR48","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.4049\/jimmunol.172.8.4941","volume":"172","author":"P Mazzi","year":"2004","unstructured":"Mazzi P, Donini M, Margotto D, Wientjes F, Dusi S. IFN-\u03b3 induces gp91phox expression in human monocytes via protein kinase C-dependent phosphorylation of PU. 1. J Immunol. 2004;172(8):4941\u201347.","journal-title":"J Immunol"},{"issue":"11","key":"1926_CR49","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1074\/jbc.M109803200","volume":"277","author":"A Kumatori","year":"2002","unstructured":"Kumatori A, Yang D, Suzuki S, Nakamura M. Cooperation of STAT-1 and IRF-1 in interferon-\u03b3-induced transcription of the gp91phox gene. J Biol Chem. 2002;277(11):9103\u201311.","journal-title":"J Biol Chem"},{"issue":"12","key":"1926_CR50","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1182\/bloodadvances.2021005776","volume":"6","author":"KJ McCann","year":"2022","unstructured":"McCann KJ, Christensen SM, Colby DH, McGuire PJ, Myles IA, Zerbe CS, et al. IFN\u03b3 regulates NAD+ metabolism to promote the respiratory burst in human monocytes. Blood Adv. 2022;6(12):3821\u201334.","journal-title":"Blood Adv"},{"issue":"3","key":"1926_CR51","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1128\/CDLI.6.3.420-424.1999","volume":"6","author":"A \u212bhlin","year":"1999","unstructured":"\u212bhlin A, L\u00e4rfars G, Elinder Gr, Palmblad J, Gyllenhammar H. Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils. Clin Diagn Lab Immunol. 1999;6(3):420\u201324.","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01926-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01926-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01926-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:02:34Z","timestamp":1777309354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01926-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01926-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}